These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enterovirus-Cardiomyocyte Interactions: Impact of Terminally Deleted Genomic RNAs on Viral and Host Functions. Bouin A; Vu MN; Al-Hakeem A; Tran GP; Nguyen JHC; Semler BL J Virol; 2023 Jan; 97(1):e0142622. PubMed ID: 36475766 [TBL] [Abstract][Full Text] [Related]
5. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3. Wang Y; Pfeiffer JK mBio; 2016 Mar; 7(2):e00119. PubMed ID: 27025249 [TBL] [Abstract][Full Text] [Related]
6. Human astrocytic cells support persistent coxsackievirus B3 infection. Zhang X; Zheng Z; Shu B; Liu X; Zhang Z; Liu Y; Bai B; Hu Q; Mao P; Wang H J Virol; 2013 Nov; 87(22):12407-21. PubMed ID: 24027313 [TBL] [Abstract][Full Text] [Related]
7. Polyamines and eIF5A hypusination facilitate SREBP2 synthesis and cholesterol production leading to enhanced enterovirus attachment and infection. Firpo MR; LoMascolo NJ; Petit MJ; Shah PS; Mounce BC PLoS Pathog; 2023 Apr; 19(4):e1011317. PubMed ID: 37071661 [TBL] [Abstract][Full Text] [Related]
8. A Kidnapping Story: How Coxsackievirus B3 and Its Host Cell Interact. Peischard S; Ho HT; Theiss C; Strutz-Seebohm N; Seebohm G Cell Physiol Biochem; 2019; 53(1):121-140. PubMed ID: 31230428 [TBL] [Abstract][Full Text] [Related]
9. In Vitro Model Systems of Coxsackievirus B3-Induced Myocarditis: Comparison of Commonly Used Cell Lines and Characterization of CVB3-Infected iCell Kraft L; Sauter M; Seebohm G; Klingel K Viruses; 2021 Sep; 13(9):. PubMed ID: 34578416 [TBL] [Abstract][Full Text] [Related]
10. Divergent Requirement for a DNA Repair Enzyme during Enterovirus Infections. Maciejewski S; Nguyen JH; Gómez-Herreros F; Cortés-Ledesma F; Caldecott KW; Semler BL mBio; 2015 Dec; 7(1):e01931-15. PubMed ID: 26715620 [TBL] [Abstract][Full Text] [Related]
11. Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection. Jrad-Battikh N; Souii A; Oueslati L; Aouni M; Hober D; Gharbi J; Ben M'hadheb-Gharbi M Curr Microbiol; 2014 Apr; 68(4):503-9. PubMed ID: 24322405 [TBL] [Abstract][Full Text] [Related]
12. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy. Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319 [TBL] [Abstract][Full Text] [Related]
13. Virus-host coevolution in a persistently coxsackievirus B3-infected cardiomyocyte cell line. Pinkert S; Klingel K; Lindig V; Dörner A; Zeichhardt H; Spiller OB; Fechner H J Virol; 2011 Dec; 85(24):13409-19. PubMed ID: 21976640 [TBL] [Abstract][Full Text] [Related]
14. Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro. Hulsebosch BM; Mounce BC Viruses; 2021 Feb; 13(2):. PubMed ID: 33669273 [TBL] [Abstract][Full Text] [Related]
15. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas. Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes. Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926 [TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus B3 infects and disrupts human induced-pluripotent stem cell derived brain-like endothelial cells. Mamana J; Humber GM; Espinal ER; Seo S; Vollmuth N; Sin J; Kim BJ Front Cell Infect Microbiol; 2023; 13():1171275. PubMed ID: 37139492 [TBL] [Abstract][Full Text] [Related]
18. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production. Liu H; Li M; Song Y; Xu W Front Immunol; 2018; 9():2479. PubMed ID: 30410495 [TBL] [Abstract][Full Text] [Related]
19. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice. Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777 [TBL] [Abstract][Full Text] [Related]
20. CVB3 Nonstructural 2A Protein Modulates SREBP1a Signaling via the MEK/ERK Pathway. Wang L; Xie W; Zhang L; Li D; Yu H; Xiong J; Peng J; Qiu J; Sheng H; He X; Zhang K J Virol; 2018 Dec; 92(24):. PubMed ID: 30258014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]